GH Research (GHRS) Consolidated Net Income (2020 - 2025)

GH Research's (GHRS) quarterly Consolidated Net Income came in at -$13.6 million in Q4 2025, down 5.01% year-on-year from -$14.3 million in Q4 2024, and up 3.29% quarter-over-quarter from -$14.1 million in Q3 2025.

GH Research (GHRS) Consolidated Net Income (2020 - 2025) Analysis & Trends

GH Research's Consolidated Net Income history runs 6 years deep, the most recent figure standing at -$13.6 million for Q4 2025.

  • On a quarterly basis, Consolidated Net Income fell 5.01% year-over-year to -$13.6 million in Q4 2025; TTM through Dec 2025 was -$46.8 million, a 8.26% decrease from a year earlier, with the FY2025 full-year figure at -$46.8 million, down 8.26% from the prior year.
  • Consolidated Net Income advanced to -$13.6 million in Q4 2025 per GHRS's latest filing, from -$14.1 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$1.4 million in Q1 2021 and bottomed at -$14.1 million in Q3 2025.
  • The 5-year median for Consolidated Net Income is -$8.0 million (2022), against an average of -$8.3 million.
  • Across the five-year window, Consolidated Net Income sank 10304.44% in 2021 and increased 22.53% in 2023, its largest moves.
  • Year by year, Consolidated Net Income stood at -$6.7 million in 2021, then declined by 19.19% to -$7.9 million in 2022, then increased by 22.53% to -$6.1 million in 2023, then slumped by 110.89% to -$13.0 million in 2024, then fell by 5.01% to -$13.6 million in 2025.
  • Per Business Quant, the three latest GHRS Consolidated Net Income figures stand at -$13.6 million (Q4 2025), -$14.1 million (Q3 2025), and -$8.8 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -37.09 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -14.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 498.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 GH Research 1.65 Bn 1.65 Bn - -13.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -13.62 Mn
Sep 30, 2025 -14.08 Mn
Jun 30, 2025 -8.83 Mn
Mar 31, 2025 -10.28 Mn
Dec 31, 2024 -12.97 Mn
Sep 30, 2024 -10.49 Mn
Jun 30, 2024 -10.83 Mn
Mar 31, 2024 -8.96 Mn
Dec 31, 2023 -6.15 Mn
Sep 30, 2023 -7.43 Mn
Jun 30, 2023 -7.79 Mn
Mar 31, 2023 -9.26 Mn
Dec 31, 2022 -7.94 Mn
Sep 30, 2022 -6.91 Mn
Jun 30, 2022 -6.72 Mn
Mar 31, 2022 -8.02 Mn
Dec 31, 2021 -6.66 Mn
Sep 30, 2021 -4.68 Mn
Jun 30, 2021 -2.61 Mn
Mar 31, 2021 -1.35 Mn